TTop stories Read More Pfizer (PFE) Q2 2025 earnings reportAugust 5, 2025 Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press |…
TTop stories Read More Trump demands that pharma companies lower drug pricesAugust 1, 2025 President Trump escalated his demands that pharma companies lower U.S. drug prices in line with what other countries…
HHeadlines Read More Claiming ‘vindication’ after escaping higher tariff rates, Australia vows to export more into the USAugust 1, 2025 Australia will seek to exploit its comparatively low tariff rate enacted by US President Donald Trump by exporting…
TTop stories Read More Vinay Prasad departs FDA | STATJuly 30, 2025 Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
TTop stories Read More Merck (MRK) earnings report Q2 2025July 29, 2025 Merck & Co. signage on the floor of the New York Stock Exchange (NYSE) in New York, US,…
TTop stories Read More UnitedHealth Group (UNH) earnings report Q2 2025July 29, 2025 UnitedHealth Group on Tuesday issued a 2025 outlook that fell short of Wall Street’s expectations, as the company’s…
TTop stories Read More FDA clears way for Sarepta Therapeutics to use Duchenne drug in some patientsJuly 29, 2025 Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
HHeadlines Read More Details Murky On Trump, Van Der Leyen Trade DealJuly 28, 2025 President of the European Commission Ursula von der Leyen shakes hands with President during a … More meeting…
TTop stories Read More As Sarepta, FDA tangle over Duchenne therapy, families are caught in the middleJuly 24, 2025 Jennifer Hill Blair recognized the Cincinnati number on her buzzing phone and slipped out of the school meeting,…
TTop stories Read More UnitedHealth facing DOJ investigation over Medicare billingJuly 24, 2025 The UnitedHealth logo on a laptop arranged in New York, US, on Friday, July 7, 2023. Gabby Jones…
TTop stories Read More Sarepta Therapeutics’ Elevidys faces ‘arduous’ path back to marketJuly 22, 2025 Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
TTop stories Read More Sarepta to pause gene therapy Elevidys shipments in U.S.July 22, 2025 Thomas Fuller | SOPA Images | Lightrocket | Getty Images Sarepta Therapeutics said on Monday it will pause…